Video: When Should Startups Start Their Economic & Reimbursement Strategy?

In this expert-led video, Dawn Bitz, President of Lazzaro Medical, explains why startups should begin planning their economic and reimbursement strategy early in development. She outlines how economic data can shape clinical endpoints and strengthen the case for commercialization.

What You’ll Learn:

Early Planning: Why reimbursement strategy should start alongside product development
Data Sources: How to use MedPAR and Premier datasets to build economic models
Strategic Integration: How to align clinical and economic evidence for FDA and payer success

Whether you’re designing a trial or preparing for market entry, this video offers a roadmap for building a strong reimbursement foundation.

Let’s Talk About Your Project

Ask a question or request a meeting with a NAMSA expert to discuss your specific project. We will follow up as quickly as possible.

First Name*

Last Name/Surname*

Business Email*

Job Title*

Company*

Company Size*

Where Are You Based?*

What is the Primary Focus of Your Inquiry?*

Location of Company Office You Work At/Report To*

Zip Code*

How can we help?*

By choosing to submit your information to contact NAMSA, you are providing NAMSA consent to process and store your information on the NAMSA Network. At any time, you can submit a request to withdraw your consent for the use of information provided by you. For additional information, please visit our Privacy Policy.

Video: When Should Startups Start Their Economic & Reimbursement Strategy?

Published:

What You’ll Learn:

Let’s Talk About Your Project